The story
Founded by Omid Cameron Farokhzad on Mar 2017.1
Overview
Mar 2017Founded1
Compare with Accelerate Diagnostics, Precipio, Inc. or BioNano Genomics, or pick any stock.
- TickerSEER on Nasdaq1
- IndustryLaboratory Analytical Instruments1
- HeadquartersRedwood City1
- Websiteseer.bio
- Incorporated inDE4
- Business address3800 Bridge Parkway, Suite 102, Redwood City, Ca 940654
- Filer categoryNon-accelerated filer, Smaller reporting company4
See how the biggest companies compare on our leaderboards
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
51.1%Gross margin5
-470.5%Operating margin5
-444.0%Net margin5
17.0%Revenue growth, 20255
-28.4%Return on equity5
-$46.2MFree cash flow5
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue9¢$8.1M
- Research and development46¢$43.9M
- Selling, general and admin45¢$42.6M
- Income tax0¢$201.0K
Out of $16.6M in revenue.5 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total revenue | $16.6M | $14.2M |
| Total cost of revenue | $8.1M | $7.1M |
| Gross profit | $8.5M | $7.1M |
| Research and development | $43.9M | $50.6M |
| Selling, general and administrative | $42.6M | $56.6M |
| Total operating expenses | $86.5M | $107.2M |
| Loss from operations | -$78.0M | -$100.1M |
| Interest income | $11.5M | $16.7M |
| Loss on equity method investment | -$5.9M | -$2.6M |
| Other expense | -$1.0M | -$417.0K |
| Total other income | $4.6M | $13.6M |
| Loss before provision for income taxes | -$73.4M | -$86.5M |
| Provision for income taxes | $201.0K | $98.0K |
| Net loss | -$73.6M | -$86.6M |
| Unrealized gain on available-for-sale securities | $323.0K | $328.0K |
| Comprehensive loss | -$73.3M | -$86.3M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $47.3M | $40.8M | |
| Short-term investments | $138.6M | $195.7M | |
| Other receivables | $1.4M | $1.9M | |
| Inventory | $7.8M | $7.4M | |
| Prepaid expenses and other current assets | $1.9M | $3.2M | |
| Total current assets | $201.5M | $253.3M | |
| Long-term investments | $54.7M | $63.1M | |
| Operating lease right-of-use assets | $20.5M | $22.8M | |
| Property and equipment, net | $14.8M | $18.6M | |
| Restricted cash | $524.0K | $524.0K | |
| Other assets | $4.1M | $8.3M | |
| Total assets | $296.1M | $366.6M | |
| Accounts payable | $5.6M | $4.6M | |
| Accrued expenses | $7.1M | $7.9M | |
| Deferred revenue | $341.0K | $408.0K | |
| Operating lease liabilities, current | $2.6M | $2.3M | |
| Other current liabilities | $29.0K | $50.0K | |
| Total current liabilities | $15.7M | $15.3M | |
| Operating lease liabilities, net of current portion | $21.1M | $23.7M | |
| Other noncurrent liabilities | $8.0K | $48.0K | |
| Total liabilities | $36.8M | $39.0M | |
| Preferred stock, $0.00001 par value; 5,000,000 shares authorized as of December 31, 2025 and 2024; zero shares issued and outstanding as of December 31, 2025 and 2024 | $0 | $0 | |
| Additional paid-in capital | $724.8M | $719.8M | |
| Accumulated other comprehensive gain | $459.0K | $136.0K | |
| Accumulated deficit | -$466.0M | -$392.4M | |
| Total stockholders equity | $259.3M | $327.6M | $396.9M |
| Total liabilities and stockholders equity | $296.1M | $366.6M | |
| Preferred stock, par value (in usd per share) | $0.00 | $0.00 | |
| Preferred stock, authorized (in shares) | 5.0M shares | 5.0M shares | |
| Preferred stock, issued (in shares) | 0 shares | 0 shares | |
| Preferred stock, outstanding (in shares) | 0 shares | 0 shares | |
| Common stock, authorized (in shares) | 99.1M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $47.3M | $40.8M | |
| Short-term investments | $138.6M | $195.7M | |
| Other receivables | $1.4M | $1.9M | |
| Inventory | $7.8M | $7.4M | |
| Prepaid expenses and other current assets | $1.9M | $3.2M | |
| Total current assets | $201.5M | $253.3M | |
| Long-term investments | $54.7M | $63.1M | |
| Operating lease right-of-use assets | $20.5M | $22.8M | |
| Property and equipment, net | $14.8M | $18.6M | |
| Restricted cash | $524.0K | $524.0K | |
| Other assets | $4.1M | $8.3M | |
| Total assets | $296.1M | $366.6M | |
| Accounts payable | $5.6M | $4.6M | |
| Accrued expenses | $7.1M | $7.9M | |
| Deferred revenue | $341.0K | $408.0K | |
| Operating lease liabilities, current | $2.6M | $2.3M | |
| Other current liabilities | $29.0K | $50.0K | |
| Total current liabilities | $15.7M | $15.3M | |
| Operating lease liabilities, net of current portion | $21.1M | $23.7M | |
| Other noncurrent liabilities | $8.0K | $48.0K | |
| Total liabilities | $36.8M | $39.0M | |
| Preferred stock, $0.00001 par value; 5,000,000 shares authorized as of December 31, 2025 and 2024; zero shares issued and outstanding as of December 31, 2025 and 2024 | $0 | $0 | |
| Additional paid-in capital | $724.8M | $719.8M | |
| Accumulated other comprehensive gain | $459.0K | $136.0K | |
| Accumulated deficit | -$466.0M | -$392.4M | |
| Total stockholders equity | $259.3M | $327.6M | $396.9M |
| Total liabilities and stockholders equity | $296.1M | $366.6M | |
| Preferred stock, par value (in usd per share) | $0.00 | $0.00 | |
| Preferred stock, authorized (in shares) | 5.0M shares | 5.0M shares | |
| Preferred stock, issued (in shares) | 0 shares | 0 shares | |
| Preferred stock, outstanding (in shares) | 0 shares | 0 shares | |
| Common stock, authorized (in shares) | 99.1M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net Income (Loss) | -$73.6M | -$86.6M |
| Stock-based compensation | $15.4M | $28.2M |
| Depreciation and amortization | $6.1M | $6.2M |
| Loss on disposal of property and equipment | $1.0M | $279.0K |
| Net amortization of premium on available-for-sale securities | $1.1M | $3.1M |
| Provision for inventory excess and obsolescence | $148.0K | $179.0K |
| Non-cash operating lease expense | -$9.0K | $91.0K |
| Loss on equity method investment | $5.9M | $2.6M |
| Accounts receivable, net | $277.0K | $487.0K |
| Prepaid expenses and other assets | $1.6M | -$92.0K |
| Inventory | -$2.9M | -$2.7M |
| Accounts payable | $1.1M | $3.4M |
| Deferred revenue | -$67.0K | $202.0K |
| Accrued liabilities and other liabilities | -$520.0K | -$1.4M |
| Net cash used in operating activities | -$44.4M | -$46.1M |
| Purchases of property and equipment | -$1.8M | -$3.6M |
| Proceeds from disposal of property and equipment | $646.0K | $343.0K |
| Purchases of available-for-sale securities | -$173.2M | -$262.9M |
| Proceeds from maturities of available-for-sale securities | $237.8M | $342.0M |
| Purchase of equity security | -$1.9M | -$10.0M |
| Net cash provided by investing activities | $61.5M | $65.9M |
| Proceeds from exercise of Class A common stock options | $56.0K | $0 |
| Repurchases of Class A common stock under share repurchase program | -$10.2M | -$11.8M |
| Taxes paid related to net settlement of restricted stock units | -$827.0K | $0 |
| Proceeds from issuance of Class A common stock in connection with employee stock purchase plan | $402.0K | $321.0K |
| Net cash used in financing activities | -$10.6M | -$11.5M |
| Net increase in cash, cash equivalents and restricted cash | $6.5M | $8.3M |
| Cash paid for income taxes | $182.0K | $154.0K |
| Capitalized stock-based compensation related to internal-use software development | $169.0K | $220.0K |
| Property and equipment purchases included in accounts payable and accrued expenses | $131.0K | $248.0K |
| Inventory transferred to property and equipment | $2.5M | $242.0K |
| Property and equipment transferred to inventory | $62.0K | $699.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led Seer, Inc, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
20202025
- FounderOmid Cameron Farokhzad1
- Chief executive officerOmid Cameron Farokhzad Dec 3, 2020 to now13
- ChairOmid Cameron Farokhzad Dec 3, 2020 to now13
- PresidentDavid R. Horn Feb 7, 2024 to now14
- PresidentOmid Cameron Farokhzad Nov 9, 2022 to Nov 3, 202315
- PresidentOmead Ostadan Dec 3, 2020 to Jun 1, 202216
- Chief financial officerDavid R. Horn Dec 3, 2020 to now17
- Chief operating officerOmead Ostadan Dec 3, 2020 to Jun 1, 202216
Board members and other officers (13)
- Chief Commercial OfficerAnthony R. Bazarko May 11, 2026 to now18
- Board memberIsaac Ro Sep 3, 2025 to now19
- Board memberNicolas H. Roelofs Phd. Aug 15, 2024 to now20
- Board memberDipchand Nishar Feb 23, 2021 to now21
- Board memberLee S. Ainslie Iii. Jun 23, 2021 to Jun 23, 202122
- Board memberRachel E. Haurwitz Nov 12, 2021 to Jun 14, 202423
- Board memberMeeta Gulyani Dec 1, 2021 to now24
- Board memberCathy Friedman Dec 3, 2020 to Jun 16, 202325
- Board memberDavid Hallal Dec 3, 2020 to Jun 14, 202426
- Board memberOmead Ostadan Dec 3, 2020 to Jun 1, 202216
- Board memberRobert S. Langer, Jr. Dec 3, 2020 to now27
- Board memberTerrance McGuire Dec 3, 2020 to now28
- General counselElona Kogan Esq. Dec 3, 2020 to Feb 23, 202429
Former names
- Seer Biosciences, Inc.Jan 4, 2018 to Jan 4, 20184
Timeline
Filings
294 filings to the SEC since October 2021: 7 annual reports, 15 quarterly reports, 52 major events, 111 insider forms, 40 large holders, 69 other. The latest 20:
- Oct 8, 20263 EDGAR
- Sep 18, 20268-K EDGAR
- Aug 19, 20264 EDGAR
- Aug 11, 202610-Q EDGAR
- Aug 11, 20268-K EDGAR
- Jul 31, 20268-K EDGAR
- Jul 31, 20268-K EDGAR
- Jul 30, 20264 EDGAR
- Jul 30, 20264 EDGAR
- Jul 30, 20264 EDGAR
- Jul 30, 20264 EDGAR
- Jul 30, 20264 EDGAR
- Jul 30, 20264 EDGAR
- Jul 28, 2026DFAN14A EDGAR
- Jul 24, 2026DFAN14A EDGAR
- Jul 22, 2026DEFA14A EDGAR
- Jul 22, 2026DFAN14A EDGAR
- Jul 20, 2026DEFA14A EDGAR
- Jul 20, 20268-K EDGAR
- Jul 20, 2026DEFA14A EDGAR
The 294 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last three years, summarized. The full record is on SEC EDGAR.
Insider trades and holders
Large holders
Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 40 such filings since October 2021, the latest 10:
- May 15, 2026SCHEDULE 13G/A
- May 4, 2026SCHEDULE 13G/A
- Apr 13, 2026SCHEDULE 13D/A
- Mar 2, 2026SCHEDULE 13D/A
- Feb 20, 2026SCHEDULE 13D
- Aug 13, 2025SCHEDULE 13G/A
- May 14, 2025SCHEDULE 13G/A
- Feb 12, 2025SCHEDULE 13G/A
- Feb 12, 2025SCHEDULE 13G
- Jan 8, 2025SCHEDULE 13G/A
From Forms 4 and Schedules 13D and 13G filed with the SEC.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 58. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Softbank Group Corp. | 5,135,383 | $8.5M | 0.0% | No change |
| Siren, L.L.C. | 2,458,673 | $4.1M | 0.1% | No change |
| Vanguard Capital Management LLC | 1,831,058 | $3.0M | 0.0% | −127,938 |
| BlackRock, Inc. | 1,428,405 | $2.4M | 0.0% | −393,199 |
| Renaissance Technologies LLC | 985,500 | $1.6M | 0.0% | +8,812 |
| Nano Cap New Millennium Growth Fund L P | 825,000 | $1.4M | 1.1% | No change |
| Citadel Advisors LLC | 519,310 | $862.1K | 0.0% | New |
| Two Sigma Investments, LP | 492,298 | $817.2K | 0.0% | −19,300 |
| Geode Capital Management, LLC | 460,430 | $764.5K | 0.0% | +37,453 |
| Bridgeway Capital Management, LLC | 459,443 | $762.7K | 0.0% | No change |
| Peapod Lane Capital LLC | 445,450 | $739.4K | 0.5% | +6,869 |
| 1888 Investments, LLC | 359,143 | $596.2K | 1.1% | No change |
| Goldman Sachs Group Inc | 246,638 | $409.4K | 0.0% | +52,465 |
| Jacobs Levy Equity Management, Inc | 222,332 | $369.1K | 0.0% | +79,090 |
| Rangeley Capital, LLC | 222,000 | $368.5K | 0.3% | +37,698 |
| Vanguard Fiduciary Trust Co | 216,961 | $360.2K | 0.0% | +1,433 |
| Dimensional Fund Advisors LP | 212,625 | $353.0K | 0.0% | −9,291 |
| Edgewood Management LLC | 200,000 | $332.0K | 0.0% | +100,000 |
| State Street Corp | 159,950 | $265.5K | 0.0% | No change |
| Morgan Stanley | 145,434 | $241.4K | 0.0% | −15,445 |
| Advisory Services Network, LLC | 142,648 | $236.8K | 0.0% | +132,648 |
| Voss Capital, LP | 137,291 | $227.9K | 0.0% | New |
| Hsbc Holdings PLC | 114,348 | $191.5K | 0.0% | No change |
| Shay Capital LLC | 94,208 | $156.4K | 0.0% | −41,282 |
| Northern Trust Corp | 78,895 | $131.0K | 0.0% | −55,665 |
13F reports cover disclosed long positions in U.S. stocks only.
Links
- Websiteseer.bio1
- X (Twitter)x.com/seer_bio1
- LinkedInwww.linkedin.com/company/seerbio1
- WikidataQ115446257
- SEC EDGARCIK 1726445
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataSeer, Inc on Wikidata
- 2SEC EDGARSeer, Inc filings on SEC EDGAR
- 3Company websiteSeer, Inc logo
- 4SEC EDGARSeer, Inc filings on SEC EDGAR
- 5SEC EDGARSeer, Inc 10-K for fiscal 2025
- 6SEC EDGARSeer, Inc 10-K for fiscal 2020
- 7SEC EDGARSeer, Inc 10-K for fiscal 2021
- 8SEC EDGARSeer, Inc 10-K for fiscal 2022
- 9SEC EDGARSeer, Inc 10-K for fiscal 2023
- 10SEC EDGARSeer, Inc 10-Q for fiscal 2025
- 11SEC EDGARSeer, Inc 10-Q for fiscal 2026
- 12SEC EDGARSeer, Inc 10-Q for fiscal 2026
- 13
- 14SEC EDGARDavid R. Horn, President
- 15SEC EDGAROmid Cameron Farokhzad, President
- 16SEC EDGAROmead Ostadan, President
- 17
- 18
- 19SEC EDGARIsaac Ro, Board member
- 20
- 21SEC EDGARDipchand Nishar, Board member
- 22SEC EDGARLee S. Ainslie Iii., Board member
- 23SEC EDGARRachel E. Haurwitz, Board member
- 24SEC EDGARMeeta Gulyani, Board member
- 25SEC EDGARCathy Friedman, Board member
- 26SEC EDGARDavid Hallal, Board member
- 27SEC EDGARRobert S. Langer, Jr., Board member
- 28SEC EDGARTerrance McGuire, Board member
- 29SEC EDGARElona Kogan Esq., General counsel